Investing Stocks آمجن · AMGN AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Aug 27, 2026 11:36 AM · Investing AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Original source: Investing